Presence of pharmaceuticals and personal care products in the environment - A concern for human health?

ACS Symposium Series

Volumn 1048, Issue , 2010, Pages 345-365

  Ducey, Sara Bachman ^a   Sapkota, Amir ^b  

^a Montgomery College   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; DISEASES; MANUFACTURE; RISK ASSESSMENT; SEWAGE;

GENERAL POPULATION; HUMAN EXPOSURES; MANUFACTURING FACILITY; OCCUPATIONAL EXPOSURE; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; RESEARCH PRIORITIES; SYSTEMATIC EVALUATION;

HEALTH;

EID: 84901689690     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2010-1048.ch017     Document Type: Conference Paper

References (64)

1. Pharmaceuticals and Personal Care Products (PPCPs), 2010. U.S. Environmental Protection Agency. http://www.epa.gov/ppcp/faq.html (accessed December 2009).
2. Daughton, C. G. Environmental stewardship and drugs as pollutants 10. Lancet 2002105, 360 (9339), 1035-1036.
3. Jones, O. A. H; Voulvoulis, N; Lester, J. N. Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol. 2004, 34, 335-350.
4. Boxall, A. B. A. The Environmental side effects of medicine. EMBO Rep. 2004, 5, 1110-1116.
5. Daughton, C. G.; Ternes, T. A. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspect. 1999, 107 (Suppl 6), 907-938.
6. Pharmaceutical Sales Estimates, 2010. PharmaPro. PharmaPro.com (accessed December 2009).
7. Carballa, M.; Omil, F.; Lema, J. M.; Llompart, M.; Garcia-Jares, C.; Rodriguez, I.; Gomez, M.; Ternes, T. Behavior of pharmaceuticals, cosmetics, and hormones in a sewage treatment plant. Water Res. 2004, 38 (12), 2918-2926.
8. Statins: The World Market, 2009-2024, 2010. BioPortfolio. http://www.bioportfolio.com/cgi-bin/acatalog/Statins-The-World-Market-2009- 2024.html (accessed February 2010).
9. Glassmeyer, S. T.; Hinchey, E. K.; Boehme, S. E.; Daughton, C. G.; Ruhoy, I. S.; Conerly, O.; Daniels, R. L.; Lauer, L.; McCarthy, M.; Nettesheim, T. G.; Sykes, K.; Thompson, V. G. Disposal practices for unwanted residential medications in the United States. Environ. Int. 2009, 35 (3), 566-572.
10. Daughton, C. G. Chemicals from the practice of healthcare: Challenges and unknowns posed by residues in the environment. Environ. Toxicol. Chem. 2009, 28 (12), 2490-2494.
11. Daughton, C. G.; Ruhoy, I. S. Environmental footprint of pharmaceuticals: The significance of factors beyond direct excretion to sewers. Environ. Toxicol. Chem. 2009, 28 (12), 2495-2521.
12. Daughton, C. G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ. Health Perspect. 2003, 111 (5), 775-785.
13. Daughton, C. G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ. Health Perspect. 2003, 111 (5), 757-774.
14. Emmanuel, E.; Pierre, M. G.; Perrodin, Y. Groundwater contamination by microbiological and chemical substances released from hospital wastewater: Health risk assessment for drinking water consumers. Environ. Int. 2009, 35 (4), 718-726.
15. Rowney, N. C.; Johnson, A. C.; Williams, R. J. Cytotoxic drugs in drinking water: A prediction and risk assessment exercise for the thames catchment in the United kingdom. Environ. Toxicol. Chem. 2009, 28 (12), 2733-2743.
16. Sapkota, A. R.; Lefferts, L. Y.; McKenzie, S.; Walker, P. What do we feed to food-production animals? A review of animal feed ingredients and their potential impacts on human health. Environ. Health Perspect. 2007, 115 (5), 663-670.
17. Cooper, E. R.; Siewicki, T. C.; Phillips, K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Sci. Total Environ. 2008715, 398 (1-3), 26-33.
18. Jjemba, P. K. The potential impact of veterinary and human therapeutic agents in manure and biosolids on plants grown on arable land: A review. Agric., Ecosyst. Environ. 2002, 93, 267-278.
19. Kools, S. A.; Boxall, A. B.; Moltmann, J. F.; Bryning, G.; Koschorreck, J., II; Knacker, T. A ranking of european veterinary medicines based on environmental risks. Integr. Environ. Assess. Manage. 2008, 4(4), ISSN.
20. Toxicological Issues Associated with PPCPs; California Department of Toxic Substances: Sacramento, CA , 2009.
21. Biosolids Applied to Land: Advancing Standards and Practices; National Research Council: Washington, DC, 2002.
22. Heidler, J.; Sapkota, A.; Halden, R. U. Partitioning, persistence, and accumulation in digested sludge of the topical antiseptic triclocarban during wastewater treatment. Environ. Sci. Technol. 2006, 40 (11), 3634-3639.
23. Lapen, D. R.; Topp, E.; Metcalfe, C. D.; Li, H.; Edwards, M.; Gottschall, N.; Bolton, P.; Curnoe, W.; Payne, M.; Beck, A. Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids. Sci. Total Environ. 2008725, 399 (1-3), 50-65.
24. Fick, J.; Soderstrom, H.; Lindberg, R. H.; Phan, C.; Tysklind, M.; Larsson, D. G. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ. Toxicol. Chem. 2009, 28 (12), 2522-2527.
25. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36 (6), 1202-1211.
26. Gros, M.; Petrovic, M.; Ginebreda, A.; Barcelo, D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36 (1), 15-26.
27. Calderón-Preciado, D. Development of an analytical procedure for the determination of emerging and priority organic pollutants in leafy vegetables by pressurized solvent extraction followed by GC-MS determination. Anal. Bioanal. Chem. 2009, 394, 1319-1327.
28. Boyds, G. R; Reemtsma, H; Grimm, D. A; Mitra, S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Lousiana, USA, and Ontario, Canada. Sci. Total Environ. 2003, 311, 135-149.
29. Lin, A. Y. C.; Yu, T. H.; Lateef, S. K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J. Hazard. Mater. 2009, 167 (1-3), 1163-1169.
30. Kim, S.; Aga, D. S. Potential ecological and human health impacts of antibiotics and antibiotic-resistant bacteria from wastewater treatment plants. J. Toxicol. Environ. Health, Part B 2007, 10 (8), 559-573.
31. Ramirez, A. J.; Brain, R. A.; Usenko, S.; Mottaleb, M. A.; O'Donnell, J. G.; Stahl, L. L.; Wathen, J. B.; Snyder, B. D.; Pitt, J. L.; Perez-Hurtado, P.; Dobbins, L. L.; Brooks, B. W.; Chambliss, C. K. Occurrence of pharmaceuticals and personal care products (PPCPs) in fish: Results of a national pilot study in the U.S. Environ. Toxicol. Chem. 2009, online May 25, 2009.
32. Sui, Q.; Huang, J.; Deng, S. B.; Yu, G.; Fan, Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010, 44 (2), 417-426.
33. Daughton, C. G. Pharmaceuticals as Environmental Pollutants: The Ramifications for Human Exposure. In International Encyclopedia of Public Health; Heggenhougen, K., Quah, S., Eds.; Academic Press: Oxford, 2008; Volume 5, pp 66-102.
34. Boxall, A. B.; Johnson, P.; Smith, E. J.; Sinclair, C. J.; Stutt, E.; Levy, L. S. Uptake of veterinary medicines from soils into plants 1. J. Agric. Food Chem. 2006, 54 (6), 2288-2297.
35. Gonzalez, M.; Miglioranza, K. S.; Aizpun de Moreno, J. E.; Moreno, V. J. Occurrence and distribution of organochlorine pesticides (OCPs) in tomato (Lycopersicon esculentum) crops from organic production. J. Agric. Food Chem 2003226, 51 (5), 1353-1359.
36. World Water Assessment Programme. The United Nations World Water Development Report 3: Water in a Changing World; UNESCO, Earthscan: Paris, London, 2009.
37. Chu, S.; Metcalfe, C. D. Analysis of paroxetine, fluoxetine, and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup, and liquid chromatography-tandem mass spectrometry. J. Chromatogr., A 2007, 1163 (1-2), 112-118.
38. Expanded Investigations of Pharmaceuticals in Fish Tissue, 2010. U.S. Environmental Protection Agency. http://www.epa.gov/waterscience/ppcp/studies/ fish-expand.html (accessed May 30, 2010).
39. Sapkota, A.; Sapkota, A. R.; Kucharski, M.; Burke, J.; McKenzie, S.; Walker, P.; Lawrence, R. Aquaculture practices and potential human health risks: Current knowledge and future priorities. Environ. Int. 2008, 34 (8), 1215-1226.
40. Barton, B. A.; Iwama, G. K. Physiological changes in fish from stress in aquaculture with emphasis on the response and effects of corticosteriods. Annu. Rev. Fish Dis. 1991, 1, 3-26.
41. Naylor, R.; Burke, M. Aquaculture and ocean resources: Raising tigers of the sea. Annu. Rev. Environ. Resour. 2005, 30, 185-218.
42. Toward Safe and Effective Use of Chemicals in Coastal Aquaculture; GESAMP Reports and Studies No. 65; Joint Group of Experts on the Scientific Aspects of Marine Environmental Protection (GESAMP): Rome, 1997.
43. Alderman, D. J.; Hastings, T. S. Antibiotic use in aquaculture: Development of antibiotic resistence-potential for consumer health risks. Int. J. Food Sci. Technol. 1998, 33, 139-155.
44. Huss, H. H., Ababouch, L., Gram, L. Assessment and Management of Seafood Safety and Quality; FAO Fisheries Technical Paper No. 444; Food and Agriculture Organization (FAO): Rome, 2004.
45. Cabello, F. C. Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment. Environ. Microbiol. 2006, 8 (7), 1137-1144.
46. Samuelsen, O. B.; Lunestad, B. T.; Husevag, B.; Holleland, T.; Ervik, A. Residues of oxolinic acid in wild fauna following medication in fish farms. Dis. Aquat. Org. 1992, 12, 111-119.
47. Guidelines for the Safe Use of Wastewater, Excreta, and Graywater. Volume 3: Wastewater and Excreta Use in Aquaculture; World Health Organization: Geneva, Switzerland, 2006; pp 1-140.
48. Little, D. C.; Edwards, P. Alternative strategies for livestock-fish integration with emphasis on Asia. Ambio 1999, 28 (2), 118-124.
49. Petersen, A.; Andersen, J. S.; Kaewmak, T.; Somsiri, T.; Dalsgaard, A. Impact of integrated fish farming on antimicrobial resistance in a pond environment. Appl. Environ. Microbiol. 2002, 68 (12), 6036-6042.
50. Food Safety and Inspection Service, U.S. Department of Agriculture. http://origin-www.fsis.usda.gov/News-&-Events/Recall-033-2001-Release/index. asp (accessed May 27, 2010).
51. Nasterlack, M.; Messerer, P.; Pallapies, D.; Ott, M. G.; Zober, A. Cancer incidence in the wastewater treatment plant of a large chemical company. Int. Arch. Occup. Environ. Health 2009, 82 (7), 851-856.
52. Lafleur, J.; Vena, J. E. Retrospective cohort mortality study of cancer among sewage plant workers. Am. J. Ind. Med. 1991, 19 (1), 75-86.
53. Friis, L.; Edling, C.; Hagmar, L. Mortality and incidence of cancer among sewage workers: A retrospective cohort study. Br. J. Ind. Med. 1993, 50 (7), 653-657.
54. Hansen, E. S.; Hilden, J.; Klausen, H.; Rosdahl, N. Wastewater exposure and health: A comparative study of two occupational groups. Occup. Environ. Med. 2003, 60 (8), 595-598.
55. Christensen, F. M. Pharmaceuticals in the environment: A human risk? Regul. Toxicol. Pharmacol. 1998, 28 (3), 212-221.
56. Schwab, B. W.; Hayes, E. P.; Fiori, J. M.; Mastrocco, F. J.; Roden, N. M.; Cragin, D.; Meyerhoff, R. D.; D'Aco, V. J.; Anderson, P. D. Human pharmaceuticals in US surface waters: A human health risk assessment. Regul. Toxicol. Pharmacol. 2005, 42 (3), 296-312.
57. Bushman, F. Conjugation, Transposition, and Antibiotic Resistance. In Lateral DNA Transfer: Mechanisms and Consequences; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2002; pp 27-72.
58. Casas, C.; Anderson, E. C.; Ojo, K. K.; Keith, I.; Whelan, D.; Rainnie, D.; Roberts, M. C. Characterization of pRAS1-like plasmids from atypical North American psychrophilic Aeromonas salmonicida. FEMS Microbiol. Lett. 2005, 242 (1), 59-63.
59. Goni-Urriza, M.; Capdepuy, M.; Raymond, N.; Quentin, C.; Caumette, P. Impact of an urban effluent on the bacterial community structure in the Arga River (Spain), with special reference to culturable gram-negative rods. Can .J. Microbiol. 1999, 45 (10), 826-832.
60. Iwane, T.; Urase, T.; Yamamoto, K. Possible impact of treated wastewater discharge on incidence of antibiotic resistant bacteria in river water. Water Sci. Technol. 2001, 43 (2), 91-99.
61. Guardabassi, L.; Lo Fo Wong, D. M.; Dalsgaard, A. The effects of tertiary wastewater treatment on the prevalence of antimicrobial resistant bacteria. Water Res. 2002, 36 (8), 1955-1964.
62. Schwartz, T.; Kohnen, W.; Jansen, B.; Obst, U. Detection of antibioticresistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol. Ecol. 200341, 43 (3), 325-335.
63. Richardson, B. J.; Lam, P. K.; Martin, M. Emerging chemicals of concern: Pharmaceuticals and personal care products (PPCPs) in Asia, with particular reference to Southern China. Mar. Pollut. Bull. 2005, 50 (9), 913-920.
64. Pomati, F.; Orlandi, C.; Clerici, M.; Luciani, F.; Zuccato, E. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol. Sci. 2008, 102 (1), 129-137.